Antibiotic resistance: a digital platform to choose the most effective therapy
The project is led by Kelyon with the IDI in Rome: a machine learning-based antibiogram predicts resistance and identifies patients at risk
2' min read
Key points
2' min read
Antibiotic resistance is now more than a threat, as antibiotic-resistant bacteria are among the most serious dangers, especially in hospitals. According to the Italian Medicines Agency, antibiotic resistance causes 12,000 deaths a year in our country, burdening the National Health Service's coffers with 2.4 billion in hospital beds.
According to the WHO, if the trend is not reversed, antibiotic resistance will be the leading cause of death in 2050 in Italy and Europe.
In fact, the increasing spread of multi-resistant bacteria threatens the sustainability of healthcare systems and makes the development of new, more effective antibiotics, but also the adoption of advanced tools for the monitoring and proper management of infections and resistance, urgent.
The project also involved the University of Salerno
.Kelyon, with the support of the Istituto Dermopatico dell'Immacolata in Rome, as part of a research project conducted with the University of Salerno, has developed AntiMO, an advanced digital platform designed to support doctors and healthcare facilities in the fight against antibiotic resistance.
"With AntiMO we wanted to put technology at the service of medicine, offering a concrete tool to support clinicians and counter one of the most urgent challenges of modern healthcare," said Gaetano Cafiero, CEO of Kelyon.
